Trust Company’s Tenet Healthcare THC Stock Holding History

Trust Company’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19	Closed	-$2.56K	–	451
2025 Q1	$2.56K	Hold	19	–	–	﹤0.01%	394
2024 Q4	$2.4K	Hold	19	–	–	﹤0.01%	381
2024 Q3	$3.16K	Buy	+19	New	+$2.87K	﹤0.01%	343

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Trust Company's THC Position: Q2 2025 in Review

Trust Company sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 19 shares — an estimated $2.56K sold.

Trust Company first reported a position in THC in Q3 2024 and held it in 3 quarters. The position peaked at $3.16K in Q3 2024. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

Trust Company reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
Trust Company sold 19 Tenet Healthcare shares in Q2 2025, an estimated $2.56K.
Trust Company first reported a position in Tenet Healthcare in Q3 2024 and held it in 3 quarters.
Trust Company's Tenet Healthcare position peaked at $3.16K in Q3 2024.
626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on Trust Company's 13F filing for Q2 2025, filed 7 Jul 2025.